1. Bone Marrow Transplantation Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia;
2. Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia;
3. Faculty of Medicine, The University of Queensland, Herston, QLD, Australia;
4. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
5. Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA;
6. Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia;
7. Envoi Pathology, Brisbane, QLD, Australia;
8. Mater Research Institute, The University of Queensland–Translational Research Institute, Brisbane, QLD, Australia;
9. Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN;
10. Centre for Experimental Immunology, Lions Eye Institute, Perth, WA, Australia;
11. Infection and Immunity Program, Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia;
12. Center for Immunity and Inflammation, New Jersey Medical School, and
13. Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers Biomedical and Health Sciences (RBHS), Newark, NJ;
14. Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia;
15. Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia; and
16. Division of Medical Oncology, The University of Washington, Seattle, WA